ELOXX PHARMACEUTICALS, INC. (ELOX) Operating income 2016–2025
ELOXX PHARMACEUTICALS, INC. (ELOX) annual operating income history from SEC filings — each fiscal year as reported.
-$6.4MFY2025 · since FY2016: -$9.8M → -$6.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.4M | -160.9% |
| FY2024 | -$2.5M | +85.7% |
| FY2023 | -$17.3M | +49.8% |
| FY2022 | -$34.4M | +47.9% |
| FY2021 | -$66.0M | -97.3% |
| FY2020 | -$33.5M | +33.8% |
| FY2019 | -$50.6M | -6.3% |
| FY2018 | -$47.6M | -133.3% |
| FY2017 | -$20.4M | -107.2% |
| FY2016 | -$9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice